ketamine has been researched along with Cardiac Death in 5 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The acute pain group did not show an opioid reduction associated with the ketamine infusions." | 4.12 | Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients. ( Anghelescu, DL; Li, Y; Morgan, KJ; Patni, T; Ryan, S; Wu, D, 2022) |
| "Ketamine was followed by Salvia divinorum (a plant containing a potent and selective κ receptor agonist) and a series of serotonergic psychedelics, including the endogenous serotonin 2A receptor agonist N,N-Dimethyltryptamine (DMT)." | 1.51 | Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. ( Cassol, H; Charland-Verville, V; Erowid, E; Erowid, F; Greyson, B; Laureys, S; Martial, C; Pallavicini, C; Sanz, C; Tagliazucchi, E; Vivot, RM; Zamberlan, F, 2019) |
| "The Near-Death Experience (NDE) is a dissociative mental state with characteristic features." | 1.28 | Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. ( Jansen, KL, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anghelescu, DL | 1 |
| Ryan, S | 1 |
| Wu, D | 1 |
| Morgan, KJ | 1 |
| Patni, T | 1 |
| Li, Y | 1 |
| Nigam, K | 1 |
| Curseen, KA | 1 |
| Beaussant, Y | 1 |
| Martial, C | 1 |
| Cassol, H | 1 |
| Charland-Verville, V | 1 |
| Pallavicini, C | 1 |
| Sanz, C | 1 |
| Zamberlan, F | 1 |
| Vivot, RM | 1 |
| Erowid, F | 1 |
| Erowid, E | 1 |
| Laureys, S | 1 |
| Greyson, B | 1 |
| Tagliazucchi, E | 1 |
| Corazza, O | 1 |
| Schifano, F | 1 |
| Jansen, KL | 1 |
1 review available for ketamine and Cardiac Death
| Article | Year |
|---|---|
Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care.
Topics: Aged; Death; Hallucinogens; Humans; Integrative Medicine; Ketamine; Palliative Care | 2023 |
4 other studies available for ketamine and Cardiac Death
| Article | Year |
|---|---|
Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients.
Topics: Acute Pain; Analgesics; Analgesics, Opioid; Child; Death; Humans; Infusions, Intravenous; Ketamine; | 2022 |
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.
Topics: Adult; Consciousness; Data Mining; Datasets as Topic; Death; Excitatory Amino Acid Antagonists; Hall | 2019 |
Near-death states reported in a sample of 50 misusers.
Topics: Adult; Aged; Analgesics; Death; Female; Humans; Interviews as Topic; Ketamine; London; Male; Middle | 2010 |
Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins.
Topics: Consciousness; Death; Humans; Ketamine; Models, Neurological; Neuropeptides; Neurosciences; Receptor | 1990 |